Ramadan fasting in diabetes-exercise in problem-solving.

AIM: Appropriate management of a diabetic patient with co-morbidities, who is willing to fast during Ramadan. Case presentation A 45 year old male patient with T2DM for 5 years, current A1c of 8.3% and other co-morbidities is currently treated with metformin 500mg BID and glimepiride 2mg. During the pre-Ramadan assessment, glimepiride 2mg was changed to extended release gliclazide 60mg. It resulted in an improvement in his glycemic and microalbuminuria status without any hypoglycemic episodes.

CONCLUSION: Appropriate risk stratification with medication adjustment and Ramadan-specific diabetes education are the important aspects of T2DM management in patients willing to fast during Ramadan.